How I treat nodular lymphocyte-predominant Hodgkin lymphoma.
Eichenauer DA, Engert A.
Blood. 2020 Dec 24;136(26):2987-2993. doi: 10.1182/blood.2019004044.
Nodular lymphocyte-predominant Hodgkin lymphoma: advances in disease biology, risk stratification, and treatment.
Salvaris RT, Allanson BM, Collins G, Cheah C.
Haematologica. 2024 Nov 1;109(11):3476-3487. doi: 10.3324/haematol.2024.285903.
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Binkley MS, Flerlage JE, Savage KJ, Akhtar S, Steiner R, Zhang XY, Dickinson M, Prica A, Major A, Hendrickson PG, Hopkins D, Ng A, Casulo C, Baron J, Roberts KB, Al Kendi J, Balogh A, Ricardi U, Torka P, Specht L, De Silva R, Pickard K, Blazin LJ, Henry M, Smith CM, Halperin D, Brady J, Brennan B, Senchenko MA, Reeves M, Hoppe BS, Terezakis S, Talaulikar D, Picardi M, Kirova Y, Fergusson P, Hawkes EA, Lee D, Doo NW, Barraclough A, Cheah CY, Ku M, Hamad N, Mutsando H, Gilbertson M, Marconi T, Viiala N, Maurer MJ, Eichenauer DA, Hoppe RT; GLOW Consortium.
J Clin Oncol. 2024 Jul 1;42(19):2271-2280. doi: 10.1200/JCO.23.01655. Epub 2024 Mar 26.
Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment.
Eichenauer DA, Hartmann S.
Expert Rev Hematol. 2023 Jul-Dec;16(8):607-615. doi: 10.1080/17474086.2023.2226859. Epub 2023 Jun 20.
Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management.
Ansell SM.
Am J Hematol. 2024 Dec;99(12):2367-2378. doi: 10.1002/ajh.27470. Epub 2024 Sep 6.
Nodular lymphocyte-predominant Hodgkin lymphoma.
Savage KJ, Mottok A, Fanale M.
Semin Hematol. 2016 Jul;53(3):190-202. doi: 10.1053/j.seminhematol.2016.05.009. Epub 2016 May 13.
Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Review of Current Literature and Case Discussion.
Sidda A, Naleid NK, Manu G, Graffeo V, Jamil MO.
J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221111767. doi: 10.1177/23247096221111767.
Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.
Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA.
Am J Surg Pathol. 2003 Oct;27(10):1346-56. doi: 10.1097/00000478-200310000-00007.
Nodular lymphocyte-predominant Hodgkin lymphoma: a unique disease deserving unique management.
Eichenauer DA, Engert A.
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):324-328. doi: 10.1182/asheducation-2017.1.324.
Diagnosis of Hodgkin lymphoma in the modern era.
Wang HW, Balakrishna JP, Pittaluga S, Jaffe ES.
Br J Haematol. 2019 Jan;184(1):45-59. doi: 10.1111/bjh.15614. Epub 2018 Nov 8.
